Massive uganda study aims to uncover true sickle cell burden
NCT ID NCT06301893
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to determine how common sickle cell trait and sickle cell disease are across Uganda by analyzing up to one million blood samples. Researchers want to create a detailed map of where the condition is most prevalent, which could help improve healthcare planning. The study includes people of all ages from different regions of Uganda.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide the first comprehensive map of sickle cell disease in Uganda, guiding public health efforts and resource allocation.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health outcomes, and results depend on accurate sampling across a large population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Makerere University
RECRUITINGKampala, Uganda
-
Minister of Health
RECRUITINGKampala, Uganda
-
National Coordinator EID Program
RECRUITINGKampala, Uganda
-
Sickle Cell Clinic Department of Pediatrics & Child Health Mulago Hospital
RECRUITINGKampala, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease